SCHEMBL24946313

SCHEMBL24946313

CC(C)(C)c1c(O)ccc(C(F)(F)F)c1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
CSNK2A1 P68400 1/20 0.38
P2RX7 Q99572 1/20 0.37
ALDH1A1 P00352 4/20 0.36
ALOX15 P16050 3/20 0.36
HSD17B10 Q99714 2/20 0.36
NR1I2 O75469 1/20 0.36
LMNA P02545 1/20 0.36
CYP2C9 P11712 1/20 0.36
MIF P14174 1/20 0.36
TYR P14679 1/20 0.36
HTT P42858 1/20 0.36
NFE2L2 Q16236 1/20 0.36
TMPRSS4 Q9NRS4 5/20 0.35
TDP1 Q9NUW8 2/20 0.34
TSHR P16473 1/20 0.34
AR P10275 2/20 0.34
HPGD P15428 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7037132 0.85 ALDH1A1 (0.45) ALDH1A1ALOX15HSD17B10NR1I2LMNA
SCHEMBL9446147 0.81 CYP3A4 (0.44) ALDH1A1ALOX15HSD17B10NR1I2LMNA
SCHEMBL7149858 0.80 ALDH1A1 (0.41) ALDH1A1ALOX15HSD17B10NR1I2LMNA
SCHEMBL23226966 0.78 TMPRSS4 (0.41) CSNK2A2CSNK2BCSNK2A1P2RX7TMPRSS4
SCHEMBL24945815 0.78 DAO (0.35) ALDH1A1ALOX15HSD17B10NR1I2LMNA
SCHEMBL24806431 0.77 CYP3A4 (0.52) ALDH1A1ALOX15HSD17B10NR1I2LMNA
SCHEMBL24945813 0.76 NOTUM (0.42) ALDH1A1ALOX15HSD17B10CYP2C9TMPRSS4
SCHEMBL24945808 0.75 ESR1 (0.39) ALDH1A1ALOX15HSD17B10NR1I2LMNA
SCHEMBL26501855 0.74 ALDH1A1 (0.32) ALDH1A1ALOX15HSD17B10NR1I2LMNA
SCHEMBL21139632 0.73 NOTUM (0.39) P2RX7ARCLCN2NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230131535-A1 ARYLMETHYLENE AROMATIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS D. E. SHAW RESEARCH, LLC 2023-04-27 US disclosed
US-20230131535-A1 ARYLMETHYLENE AROMATIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS D. E. SHAW RESEARCH, LLC 2023-04-27 US disclosed
US-20230026611-A1 ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS D. E. SHAW RESEARCH, LLC 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026611-A1 ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS KCNA3, KCNH2, KCNJ2 CSNK2A2 948/4885CSNK2B 546/4885CSNK2A1 1019/4885
US-20230131535-A1 ARYLMETHYLENE AROMATIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS KCNJ2, KCNA3, KCNK3 CSNK2A2 898/4885CSNK2B 646/4885CSNK2A1 935/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.